Skip to main content
Top
Published in: International Journal of Clinical Oncology 6/2011

01-12-2011 | Case Report

A case of acute aortic thrombosis after cisplatin-based chemotherapy

Authors: Suk Jae Hahn, Jin Young Oh, Jeung Sook Kim, Do Yeun Kim

Published in: International Journal of Clinical Oncology | Issue 6/2011

Login to get access

Abstract

Cisplatin-based therapy is associated with various toxicities, including renal failure and neuropathy. However, acute arterial thrombosis is also a possible toxic effect of cisplatin, one that has been documented in a few cases worldwide. Here we present a rare case of ascending aortic thrombosis occurring 9 days after cisplatin-based chemotherapy in a 74-year-old male who was diagnosed with malignant pleural effusion suggestive of non-small cell lung cancer. The patient did not have any predisposing factor for the occurrence of an aortic thrombus before cisplatin-based chemotherapy. Thus, we suggest that the hypercoagulable state occurred secondary to cisplatin-based chemotherapy and was additive to the malignancy itself, causing aortic thrombosis. The patient was treated successfully with low-molecular-weight heparin and warfarin.
Literature
1.
go back to reference Numico G, Garrone O, Dongiovanni V et al (2005) Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer 103:994–999PubMedCrossRef Numico G, Garrone O, Dongiovanni V et al (2005) Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer 103:994–999PubMedCrossRef
2.
go back to reference Starling N, Rao S, Cunningham D et al (2009) Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol 27:3786–3793PubMedCrossRef Starling N, Rao S, Cunningham D et al (2009) Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol 27:3786–3793PubMedCrossRef
3.
go back to reference Hicks LK, Cheung MC, Ding K et al (2009) Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer 115:5516–5525PubMedCrossRef Hicks LK, Cheung MC, Ding K et al (2009) Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer 115:5516–5525PubMedCrossRef
4.
go back to reference Içli F, Karaoğuz H, Dinçol D et al (1993) Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 72:597–593 Içli F, Karaoğuz H, Dinçol D et al (1993) Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 72:597–593
5.
go back to reference Prandoni P, Piccioli A, Girolami A (1999) Cancer and venous thromboembolism: an overview. Haematologica 84:437–445PubMed Prandoni P, Piccioli A, Girolami A (1999) Cancer and venous thromboembolism: an overview. Haematologica 84:437–445PubMed
6.
go back to reference Babu SC, Shah PM, Nitahara J (1995) Acute aortic occlusion—factors that influence outcome. J Vasc Surg 21:567–572 Babu SC, Shah PM, Nitahara J (1995) Acute aortic occlusion—factors that influence outcome. J Vasc Surg 21:567–572
7.
go back to reference Barceló R, López-Vivanco G, Mañé JM et al (2000) Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases. Ann Oncol 11:1191–1194PubMedCrossRef Barceló R, López-Vivanco G, Mañé JM et al (2000) Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases. Ann Oncol 11:1191–1194PubMedCrossRef
8.
go back to reference Dieckmann KP, Gehrckens R (2009) Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma—a case report. BMC Cancer 9:459–462 Dieckmann KP, Gehrckens R (2009) Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma—a case report. BMC Cancer 9:459–462
9.
go back to reference Poirée S, Monnier-Cholley L, Tubiana JM et al (2004) Acute abdominal aortic thrombosis in cancer patients. Abdom Imaging 29:511–513PubMedCrossRef Poirée S, Monnier-Cholley L, Tubiana JM et al (2004) Acute abdominal aortic thrombosis in cancer patients. Abdom Imaging 29:511–513PubMedCrossRef
10.
go back to reference Morlese JF, Jeswani T, Beal I et al (2007) Acute ventricular and aortic thrombosis post chemotherapy. Br J Radiol 80:e75–e77PubMedCrossRef Morlese JF, Jeswani T, Beal I et al (2007) Acute ventricular and aortic thrombosis post chemotherapy. Br J Radiol 80:e75–e77PubMedCrossRef
11.
go back to reference Mathews J, Goel R, Evans WK et al (1997) Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer. J Cancer Chemother Pharmacol 40:19–22CrossRef Mathews J, Goel R, Evans WK et al (1997) Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer. J Cancer Chemother Pharmacol 40:19–22CrossRef
12.
go back to reference Weijl NI, Rutten MF, Zwinderman AH et al (2000) Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol 18:2169–2178PubMed Weijl NI, Rutten MF, Zwinderman AH et al (2000) Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol 18:2169–2178PubMed
13.
go back to reference Walsh J, Wheeler HR, Geczy CL (1992) Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br J Haematol 81:480–488PubMedCrossRef Walsh J, Wheeler HR, Geczy CL (1992) Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br J Haematol 81:480–488PubMedCrossRef
14.
go back to reference Licciarello JT, Moake JL, Rudy CK et al (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300CrossRef Licciarello JT, Moake JL, Rudy CK et al (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300CrossRef
15.
go back to reference Dvorak HF, Brown LF, Detmar M et al (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029–1039PubMed Dvorak HF, Brown LF, Detmar M et al (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029–1039PubMed
16.
go back to reference Kuenen BC, Levi M, Meijer JC et al (2003) Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and angiogenesis inhibitor SU5416. J Clin Oncol 21:2192–2198PubMedCrossRef Kuenen BC, Levi M, Meijer JC et al (2003) Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and angiogenesis inhibitor SU5416. J Clin Oncol 21:2192–2198PubMedCrossRef
17.
go back to reference Lü CF, Yu HJ, Hou JX et al (2008) Increased procoagulant activity of red blood cells in the presence of cisplatin. Chin Med J 121:1775–1780PubMed Lü CF, Yu HJ, Hou JX et al (2008) Increased procoagulant activity of red blood cells in the presence of cisplatin. Chin Med J 121:1775–1780PubMed
18.
go back to reference Vogelzang NJ, Torkelson JL, Kennedy BJ (1985) Hypomagnesemia, renal dysfunction, and Raynaud’s phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer 56:2765–2770PubMedCrossRef Vogelzang NJ, Torkelson JL, Kennedy BJ (1985) Hypomagnesemia, renal dysfunction, and Raynaud’s phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer 56:2765–2770PubMedCrossRef
Metadata
Title
A case of acute aortic thrombosis after cisplatin-based chemotherapy
Authors
Suk Jae Hahn
Jin Young Oh
Jeung Sook Kim
Do Yeun Kim
Publication date
01-12-2011
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 6/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-011-0205-7

Other articles of this Issue 6/2011

International Journal of Clinical Oncology 6/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine